Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | COPD Clinical Trials in Phoenix | 149 Studies

Clinical Trials COPDPhoenix

COPD Clinical Trials in Phoenix

Find 149 clinical trials for copd near Phoenix, Arizona. Connect with research centers in your area.

All COPD trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 149 trials

CompletedA Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)This study evaluated the effect of inhaled aclidinium bromide on exercise endurance and in reducing resting and dynamic lung hyperinflation in patients with moderate to severe…NCT00500318·Jasper, Alabama and 51 others

PreviousPage 3 of 8Next

COPD Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTiotropium In ExerciseThe objective of this study is to evaluate the effects on exercise duration of 96 weeks treatment with 18 mcg tiotropium (Spiriva HandiHaler) daily as compared to placebo, in…NCT00525512·Jasper, Alabama and 61 others

CompletedEfficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)To evaluate the efficacy and safety of LAS 34273 compared to placebo in patients with moderate to severe COPD during one year of treatment.NCT00358436·Jasper, Alabama and 119 others

CompletedEffect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)The aim of the study is to compare the effect of roflumilast on exacerbation rate and pulmonary function in patients with chronic obstructive pulmonary disease (COPD).NCT00297115·Bayou La Batre, Alabama and 286 others

RecruitingA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseThis Phase IIb dose-ranging study will evaluate the efficacy and safety of 2 different doses of AZD6793 compared with placebo tablets in participants with moderate to very severe…NCT07082738·Birmingham, Alabama and 366 others

RecruitingEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeThis is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in…NCT07190209·Chandler, Arizona and 313 others

CompletedCo-administration of Olodaterol Respimat® and Tiotropium Handihaler®The overall objective of this study is to assess efficacy and safety of 12 weeks, once daily, orally inhaled co-administration of olodaterol 5 µg (delivered by the Respimat®…NCT01696058·Anniston, Alabama and 93 others

CompletedProcalcitonin Antibiotic Consensus Trial (ProACT)The ProACT study is a 5 year, multicenter study that will test the effect of implementation of a novel procalcitonin guideline on antibiotic use and adverse outcomes in Emergency…NCT02130986·Birmingham, Alabama and 12 others

CompletedA Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPDThe purpose of this study is to evaluate the safety and efficacy of the concomitant treatment of formoterol fumarate with tiotropium bromide compared to treatment with tiotropium…NCT00308191·Phoenix, Arizona and 16 others

TerminatedStage 1 Study of ARALAST NP and GLASSIA in A1PI DeficiencyThe purpose of this study is to conduct a pilot study to evaluate the safety and efficacy of weekly administration of Alpha1-Proteinase Inhibitor (A1PI) augmentation therapy in…NCT02722304·Peoria, Arizona and 16 others

UnknownSeasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary DiseaseTo evaluate the magnitude of the humoral immune responses to quadrivalent vs trivalent influenza vaccines in adults between the age of 50 and 64 years with a prior diagnosis of…NCT02563184·Phoenix, Arizona

CompletedPivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 InflammationPrimary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary Disease (COPD) as measured…NCT04456673·Cullman, Alabama and 333 others

CompletedA Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) PatientsPatients with Chronic Obstructive Pulmonary Disease (COPD) suffer from frequent and recurrent acute exacerbations (AECB) which are associated with enormous healthcare expenditures…NCT00739648·Haleyville, Alabama and 38 others

CompletedTwo-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPDThis is a placebo-controlled, double-blind, parallel, randomized, two-part, dose-confirming clinical study characterizing the pharmacodynamic effects of pulsed iNO using the…NCT01728220·Jasper, Alabama and 42 others

CompletedEfficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)This study compared the 14-day bronchodilator efficacy of indacaterol with that of placebo and salmeterol.NCT01089127·Florence, Alabama and 68 others

CompletedA Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.The purpose of this study is to test if the vaccine is working well in COPD patients aged 40 to 80 years old to reduce episodes of worsening symptoms ("exacerbations") and to…NCT03281876·Mesa, Arizona and 66 others

Not yet recruitingThe AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary DiseaseThis study is open to adults aged 40 years and older who have chronic obstructive pulmonary disease (COPD) with ongoing symptoms.NCT07907991·Birmingham, Alabama and 25 others

CompletedStudy to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)Primary Objective: Primary population (former smokers cohort): \- Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe…NCT04751487·Phoenix, Arizona and 237 others

CompletedA Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic SubjectsThis study will assess the efficacy and safety of multiple dose levels of AZD7594 administered once daily (QD) by inhalation in a 12-week treatment period on asthma subjects.NCT03622112·Sheffield, Alabama and 93 others

CompletedA Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)This study is a 12-week, multicenter, randomized, double blind, parallel group, placebo-controlled study.NCT02152605·Phoenix, Arizona and 53 others

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia